BSEM - Company ID 0001658678
No parsed quarterly data available for BIOSTEM TECHNOLOGIES yet.
BIOSTEM TECHNOLOGIES reported operating cash flow of $9.94M for fiscal year 2025. That is down 59.4% from $24.46M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.